Akili, Inc. (AKLI)
- Previous Close
0.4272 - Open
0.4392 - Bid 0.4276 x 200
- Ask 0.4413 x 100
- Day's Range
0.4200 - 0.4400 - 52 Week Range
0.1910 - 1.6700 - Volume
117,760 - Avg. Volume
3,989,283 - Market Cap (intraday)
34.457M - Beta (5Y Monthly) 1.70
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.65
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.
www.akiliinteractive.com68
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AKLI
Performance Overview: AKLI
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AKLI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AKLI
Valuation Measures
Market Cap
33.58M
Enterprise Value
-26.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
19.91
Price/Book (mrq)
0.57
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-35.83%
Return on Equity (ttm)
-70.32%
Revenue (ttm)
1.68M
Net Income Avi to Common (ttm)
-59.49M
Diluted EPS (ttm)
-0.7600
Balance Sheet and Cash Flow
Total Cash (mrq)
75.15M
Total Debt/Equity (mrq)
26.46%
Levered Free Cash Flow (ttm)
-36.47M
Research Analysis: AKLI
Company Insights: AKLI
AKLI does not have Company Insights